Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.

scientific article published on 16 February 2016

Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030707189
P356DOI10.1186/S40644-016-0062-8
P932PMC publication ID4756529
P698PubMed publication ID26883745
P5875ResearchGate publication ID295097753

P50authorJulia ChalayeQ115792942
Eva EvangelistaQ115792945
Alexis LaurentQ48141150
Emmanuel IttiQ55441652
Thomas DecaensQ62096202
P2093author name stringDaniel Azoulay
Julien Calderaro
Christophe Duvoux
Alain Rahmouni
Alain Luciani
Frederic Pigneur
Laurence Baranes
Charlotte Costentin
Samia Boussouar
Melanie Chiaradia
Shih-Jui Lin
P2860cites workSeparation of diffusion and perfusion in intravoxel incoherent motion MR imagingQ22065375
Management of hepatocellular carcinoma: An updateQ27860530
Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survivalQ73576933
Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosisQ81877991
Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic gradeQ84263690
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinomaQ86210555
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinomaQ86830937
¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary studyQ28687190
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosisQ29619508
Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.Q31120242
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot studyQ33384609
Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factorQ33830807
Positron emission tomography scanning in the evaluation of hepatocellular carcinomaQ33939061
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implicationsQ34207073
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosisQ34515064
Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor RegistryQ34802516
Hepatocellular carcinoma: epidemic and treatmentQ35739058
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervixQ36522127
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantationQ37130713
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisQ37341959
Oncologic applications of diffusion-weighted MRI in the body.Q37978220
Tumor response assessments with diffusion and perfusion MRI.Q37995577
Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study.Q38134706
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.Q38430018
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancerQ38471361
MRI and PET in monitoring response in lymphomaQ39976754
Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantationQ43955396
Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography.Q45908631
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinomaQ46048048
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.Q46380110
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this settingQ46454995
Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?Q46579579
Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.Q51527882
Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.Q51791527
Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.Q53102653
Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?Q53183858
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.Q53239547
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.Q53350866
Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?Q53515473
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppressionQ57000083
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan CriteriaQ63190284
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PETQ71749192
P921main subjecthepatocellular carcinomaQ1148337
liver transplantationQ1368191
Fluorodeoxyglucose Positron Emission Tomography/ Computed TomographyQ130273251
P304page(s)4
P577publication date2016-02-16
P1433published inCancer ImagingQ2577267
P1476titleFunctional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation
P478volume16

Reverse relations

cites work (P2860)
Q89701966Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection
Q58604547Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
Q42085639Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates
Q64078084F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
Q88791892Hepatocellular carcinoma: when is liver transplantation oncologically futile?
Q58583425Microvascular Invasion in HCC: The Molecular Imaging Perspective
Q58584963Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience
Q40974763Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient
Q58566698Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation

Search more.